Larvol Delta - Alentis-Announces-Positive-Topline-Results-from-Two-Studies-of-Lixudebart-ALEF02-in-Patients-with-ANCARPGN-and-Advanced-Liver-Fibrosis

lixudebart (ALE.F02) - Alentis Therap

https://www.businesswire.com/news/home/20250109789929/en/Alentis-Announces-Positive-Topline-Results-from-Two-Studies-of-Lixudebart-ALE.F02-in-Patients-with-ANCA-RPGN-and-Advanced-Liver-Fibrosis

Jan 9, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next